Breakthrough Treatment of Herpes Simplex Labialis Virus (Cold Sores)
- FDA De Novo clearance for sale in the USA.
- CE marked device for sale in Europe.
- Clinical data.
- 200,000+ devices sold, compelling user reviews.
- Further research data for potential treatment of antibiotic resistant bacterial infections.
- Granted Patents across 22 territories.
Cosmetic Anti-aging Device
- Product development phase.
- Clinical data.
- 12 Granted, 2 pending Patents across 14 territories.
Treating Hyperpigmentation Conditions
- Product developed, clinical development phase.
- 2 pending global patents.
Dry Eye Age-Related Macular Degeneration & Age-related Hearing Loss
- Clinical data.
- 7 Granted, 1 pending patent across 8 territories.
New Therapy Opportunities in Respiratory, Circulatory and Inflammatory Disease
- Concept validation phase with preliminary clinical data.
- 6 Granted patents, 1 pending application, in 7 countries.
Our Clinically Proven Photo Therapy Platform
The clinical use of 1072nm (nanometer) near-infrared light has been the focus of intense academic research.
Virulite LLC has secured global patents on the method of delivering this unique light therapy and we are now seeking partners or buyers to commercialise this breakthrough technology platform.
Our device development efforts to date have concentrated on cold sore treatment and we have secured both FDA clearance and CE marks that have enabled encouraging first device sales in the US and Europe.
Intellectual Property
Our diverse and mature patent portfolio gives us confident protection of the essential methods required for all future device embodiments.
Our IP strategy has exploited the known manufacturing tolerances of semiconductor light sources, meaning that any future competitors would only have freedom to develop devices outside of the clinically effective range.
Attracting Partners to Scale
This Breakthrough Technology
With a lengthy ownership matter now resolved, we are, for the first time, attracting partners interested in acquiring a novel technology platform that has already disrupted the cold sore treatment market and looks to lead device therapies in further globally relevant categories.
Our patents, clinical data and early sales stand up to robust scrutiny. Talk to us.
©Virulite LLC 2016
